Experimental application to the human body in Britain this week



[ad_1]

Image is symbolic. Image: Reuters

Oxford University The Jenner Institute was established in 2005 with funding from the British government and various British charities. The goal is to research and develop vaccines against infectious diseases. Edward Jenner is said to be the father of the vaccine. Guti was one of the inventors of the spring vaccine about 200 years ago. He didn’t stop inventing the smallpox vaccine. His contribution to attracting a large part of the population under this vaccine is eternal.

The scientist of this organization said. Sarah Gilbert. It works with viruses. A team of Oxford scientists led by Saraha began work on the vaccine in January. In March, a British government agency provided a grant of Rs 22 crore for the study. Sarah and her team have previous experience in developing vaccines for other infectious diseases. This experience is expected to play an important role in the development of experimental coronary vaccines.

Around 70 vaccines have been developed so far. Two have been applied to the human body in the United States and China. This will be the third test when Oxford starts. Where the experimental vaccine will be applied directly to the human body. There is no history of vaccines that have been vaccinated in just four months. Scientists have announced that the test will end first.

People who can participate in the test are selected. There are a number of conditions in which a person with coronary heart disease or recovery cannot be evaluated. If you have a fever, you cannot participate. The reason is very simple. The body of a person infected with a crown produces antibodies against the virus. And the purpose of the vaccine is to produce antibodies. There will be two groups in one stage of the study.

One group will receive the experimental coronary vaccine and the other group the conventional meningitis vaccine. The doctor or patient will not know who received the vaccine for what disease. Each patient has a code. Each dose of vaccine also has a specific code. The only thing stored on the computer is the details of who received which vaccine. This procedure is called a randomized, controlled clinical trial. They will all be evaluated regularly after a few days. If those who were vaccinated against meningitis have been infected with a virus; The vaccine will be considered effective if those who were vaccinated with the coronavirus have not been infected.

It is worth mentioning here that if the crown infection begins to subside naturally a lot in the coming months, the people participating in the test will also be less infected. It is also important that a part of the participants become infected to evaluate the effectiveness of the vaccine. If this vaccine is effective and safe in the human body, production will have to start in bulk.

The head of the project. Sarah Gilbert is optimistic. He thinks the vaccine has an 80 percent chance of being effective. Vaccines for approximately 10 diseases have been developed in the past using this vaccine technology. Thousands of people are using vaccines for other diseases made with this technology. Learn about many possible side effects. The inventors thought that a fever or some body pain might occur after taking the vaccine. This side effect is seen in almost all vaccines. Remember, the effectiveness and side effects can be known for sure after the end of the test.

The inability to obtain the desired results is a common occurrence in clinical trials. Dr. Sarah Gilbert says that the vaccine, if effective, could cover everyone from children to the elderly. Vaccines can also be effective in people with diabetes. Antibodies are produced in the body after coronavirus infection. But scientists are skeptical about whether these antibodies are chronic. That is, even if he is attacked once, there is a risk of being attacked again.

Sarah says that once the vaccine is administered, it is possible to develop long-term resistance to the coronavirus. The vaccine will work even if the crown changes its shape. Hopefully, Oxford University will make this vaccine available to everyone around the world as soon as possible. The name will only have a price. Oxford University will make no profit. The cost of making the vaccine will be determined by the price. The British government and various agencies are preparing to make millions of vaccines by September if it works.

This announcement to provide vaccines for all once again demonstrated the equal loyalty of science, scientists to all countries, castes, nations. Everyone has the right to the benefits of science and the world. The wait is just in time. Stay safe until then. Listen to expert advice.

Dr. Subrata Bose: Global Head of Clinical Trial Analysis, an expat Bangladeshi pharmaceutical company and multinational.
Email: [email protected]



[ad_2]